A 54 year old man from New Hampshire received a genetically modified pig kidney transplant on June, 14 at Massachusetts General Hospital. The surgery is part of experimental xenotransplant research aimed to determine whether animal organs might be viable solutions one day, addressing severe shortage of human donor kidneys. Doctors report that the patient is faring well so far, and he stated that he wanted to contribute to the scientific progress. This marks a significant step as clinical xenotransplant trials are about to formally begin. Read More

Other Posts

We are pleased to spotlight a valued board member of our Bioethics Education organization, Dr. Frederick L. Licciardi, MD, a Professor in the Department of Obstetrics and Gynecology at NYU Grossman School of Medicine and [...]

A 2026 National Defense University report from Dr. Giordano lays out how biodeterrence must extend beyond biological weapons to any action that produces biological harm, blurring traditional boundaries. This shift calls for coordinated responses across [...]

A recent article from The Atlantic talks about a Dutch psychiatrist who administered euthanasia to psychiatric patients including teenagers. These cases raise a difficult tension between autonomy versus vulnerability and choice versus illness. In the Netherlands, [...]

Japan has approved the world’s first treatments made from reprogrammed human cells, capable of becoming almost any tissue. These therapies aim to restore brain cells in Parkinson’s disease and repair damaged heart muscle. What makes [...]

During the 2025 Winter School, we had the honor of welcoming Dr. James Giordano as a guest speaker. He delivered a lecture on the convergence of neuroscience and artificial intelligence—an increasingly significant topic in today’s [...]

Chile has eliminated leprosy, becoming the first country in the Americas to reach this public health milestone. Leprosy, also known as Hansen’s disease, is a neglected tropical disease that affects the skin and nerves. The [...]